Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries CVS Health Corp (NY: CVS ) 55.65 UNCHANGED Streaming Delayed Price Updated: 7:00 PM EDT, May 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about CVS Health Corp < Previous 1 2 3 Next > CVS Health Stock Has a Silver Lining Called Value May 20, 2024 As integrated healthcare retailer and insurer CVS Health prioritizes profits, it presents investors with a value not seen in years Via MarketBeat ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation – CVS May 15, 2024 From The Rosen Law Firm PA Via GlobeNewswire ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation - CVS May 14, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation - CVS May 14, 2024 WHY: NEW YORK, NY - (NewMediaWire) - May 14, 2024 - Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of CVS Health... Via TheNewswire.com CVS Corp. (NYSE: CVS) Making Surprising Moves in Tuesday Session December 05, 2023 Via Investor Brand Network CVS INVESTOR NEWS: ROSEN, SKILLED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation - CVS May 12, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire CVS INVESTOR NEWS: ROSEN, SKILLED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation - CVS May 12, 2024 WHY: NEW YORK, NY - (NewMediaWire) - May 12, 2024 - Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of CVS Health... Via TheNewswire.com ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation – CVS May 10, 2024 From The Rosen Law Firm PA Via GlobeNewswire Bounce Alert: 3 Large Caps With RSIs Too Good To Ignore May 10, 2024 The sudden divergence has made clear some laggards who have ultra-low RSI readings that might just be too good to ignore. Here are 3 worth watching closely. Via MarketBeat Topics Economy Exposures Interest Rates ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation – CVS May 09, 2024 From The Rosen Law Firm, P.A. Via Business Wire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors May 03, 2024 From Glancy Prongay & Murray LLP Via Business Wire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors May 02, 2024 From Law Offices of Howard G. Smith Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors May 02, 2024 From The Law Offices of Frank R. Cruz Via Business Wire INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm May 01, 2024 From Schall Law Via GlobeNewswire Humana Leaves Shareholders in Limbo on 2025 EPS Guidance May 01, 2024 Health insurer Humana reported Q1 2024 earnings, getting a less dramatic reaction than its Q4 2023 report, causing shares to tumble more than 13%. Via MarketBeat CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens? April 30, 2024 CVS stock is making its way above Walgreens as a potential watchlist addition. Fundamentals and price targets see the stock making a comeback this year. Via MarketBeat DoorDash: 5 Compelling Reasons to Buy the Dip April 29, 2024 DoorDash Inc. (NASDAQ: DASH) is the leading restaurant and food delivery service in the United States - should you buy the dip? Via MarketBeat Topics Death Exposures Death 5 High-Yielding Oversold Stocks with Bullish Ratings April 26, 2024 Investors have favored defensive sectors in the short term, and oversold high-yielding names might become more in play as tensions rise and the market pulls in. Via MarketBeat Topics Economy Exposures Interest Rates The Honest Company is Undergoing an Honestly Solid Turnaround March 19, 2024 The Honest Company stock is up 30% after the company issued a bullish outlook for 2024 revenue and earnings, particularly in the second half of the year Via MarketBeat Topics Initial Public Offering Exposures Securities Market AM Best Affirms Credit Ratings of Most of CVS Health Corporation’s Aetna Inc. Subsidiaries; Withdraws Credit Ratings of Members of Texas Health Aetna March 13, 2024 From AM Best Via Business Wire Can UnitedHealth Group afford to keep Medicare Advantage plans? February 19, 2024 UnitedHealth Group has, to date, been unaffected by the rising costs of Medicare Advantage; investors must decide if that shoe is yet to drop Via MarketBeat S&P 500 rockets to new highs as earnings beat estimates February 09, 2024 The S&P 500 hits new highs as 10 of the 11 S&P sectors report positive Q4 earnings surprises. The tech and energy sectors are among the earnings leaders. Via MarketBeat Topics ETFs Earnings Stocks Exposures Financial US Equities Humana EPS shocker. Are Medicare Advantage plans in jeopardy? January 30, 2024 Humana shares are falling after the health insurance carrier reported a bombshell when it cut its 2024 and 2025 earnings guidance Via MarketBeat MarketBeat Week in Review – 1/15 - 1/19 January 20, 2024 The market continues to bounce back and forth as investors wait on news from the Federal Reserve later this month, but inflation may still be the bigger story Via MarketBeat Topics Economy Exposures Economy Interest Rates Are CVS store closures prescription for better financial health? January 17, 2024 CVS plans to close dozens of Target pharmacies starting in February. Amid retail pharmacy challenges, CVS is shifting toward the managed-care industry. Via MarketBeat Topics Economy Exposures Interest Rates Walgreens Boots Alliance: Is it time to take this Dog for a walk? January 04, 2024 Walgreens cut its dividend in half to right-size the payment and preserve cash flow; the stock still yields about 4% and trades at a deep value. Via MarketBeat Topics Stocks Exposures US Equities Quick list of bargain stocks to end the year December 15, 2023 Stocks are soaring after a FED dovish pivot, making these value stocks all the more attractive today. Analysts have built up cases as to why they will rally Via MarketBeat MarketBeat Week in Review – 12/4 - 12/8 December 09, 2023 Stocks finished in the green to close the week; investors believe the jobs report will allow the Fed to leave interest rates unchanged when they meet next week Via MarketBeat Topics Economy Exposures Interest Rates Is CVS stock ready for a rebound? December 07, 2023 After consolidating from this year's selloff, for those of us on the sidelines, this is about as clear a low as you can expect to see. Via MarketBeat Mega merger in the works? Humana, Cigna explore big deal December 02, 2023 Humana and Cigna are exploring a merger, aiming to conclude the deal before year-end, creating a healthcare giant with a potential market value of $137 billion. Via MarketBeat < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.